Skip to main content

Young Caroline's Form 4 filing

Cumberland Pharmaceuticals Inc (CPIX) ยท filed Sep 10, 2021

Accession no.
0001209191-21-055488
Filed
Sep 10, 2021
Trade date
Apr 16-May 27, 2021
Filing delay
147 daysLate
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 30 non-derivative transactions. Open-market purchases total $1.29K. It was filed 147 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Young CarolineCIK 0001684087Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Apr 16, 2021Common StockPPurchaseAcquired+15$3.03+$45.4511,948Direct
Apr 19, 2021Common StockPPurchaseAcquired+15$3.04+$45.611,963Direct
Apr 20, 2021Common StockPPurchaseAcquired+15$3.02+$45.311,978Direct
Apr 21, 2021Common StockPPurchaseAcquired+15$2.97+$44.5511,993Direct
Apr 22, 2021Common StockPPurchaseAcquired+15$2.96+$44.412,008Direct
Apr 23, 2021Common StockPPurchaseAcquired+15$2.99+$44.8512,023Direct
Apr 26, 2021Common StockPPurchaseAcquired+15$2.97+$44.5512,038Direct
Apr 27, 2021Common StockPPurchaseAcquired+15$2.94+$44.112,053Direct
Apr 28, 2021Common StockPPurchaseAcquired+15$2.94+$44.112,068Direct
Apr 29, 2021Common StockPPurchaseAcquired+15$2.89+$43.3512,083Direct
Apr 30, 2021Common StockPPurchaseAcquired+15$2.78+$41.712,098Direct
May 3, 2021Common StockPPurchaseAcquired+15$2.66+$39.912,113Direct
May 4, 2021Common StockPPurchaseAcquired+15$2.66+$39.912,128Direct
May 5, 2021Common StockPPurchaseAcquired+15$2.73+$40.9512,143Direct
May 6, 2021Common StockPPurchaseAcquired+15$2.74+$41.112,158Direct
May 7, 2021Common StockPPurchaseAcquired+15$2.73+$40.9512,173Direct
May 10, 2021Common StockPPurchaseAcquired+15$2.71+$40.6512,188Direct
May 11, 2021Common StockPPurchaseAcquired+15$2.68+$40.212,203Direct
May 12, 2021Common StockPPurchaseAcquired+15$2.86+$42.912,218Direct
May 13, 2021Common StockPPurchaseAcquired+15$2.88+$43.212,233Direct
May 14, 2021Common StockPPurchaseAcquired+15$2.81+$42.1512,248Direct
May 17, 2021Common StockPPurchaseAcquired+15$2.84+$42.612,263Direct
May 18, 2021Common StockPPurchaseAcquired+15$2.89+$43.3512,278Direct
May 19, 2021Common StockPPurchaseAcquired+15$2.83+$42.4512,293Direct
May 20, 2021Common StockPPurchaseAcquired+15$2.94+$44.112,308Direct
May 21, 2021Common StockPPurchaseAcquired+15$3.06+$45.912,323Direct
May 24, 2021Common StockPPurchaseAcquired+15$3.05+$45.7512,338Direct
May 25, 2021Common StockPPurchaseAcquired+15$2.91+$43.6512,353Direct
May 26, 2021Common StockPPurchaseAcquired+15$2.85+$42.7512,368Direct
May 27, 2021Common StockPPurchaseAcquired+15$2.94+$44.112,383Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)